Clinical Trial of Stem Cell Based Tissue Engineered Laryngeal Implants

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2018

Primary Completion Date

May 25, 2018

Study Completion Date

May 25, 2018

Conditions
Disorder of Upper Respiratory SystemLaryngostenosisTracheal Stenosis
Interventions
OTHER

Stem cell based tissue engineered partial laryngeal implants

Stem cells from the patient receiving the implant are removed from the bone marrow, and are then grown on the scaffold in the laboratory. These cells will form the cartilage in the wall of the scaffold. The implant can be considered 'living' due to the cells grown on it, and this type of treatment is referred to as 'tissue engineering' or 'regenerative medicine'. Once these cells have attached and started to grow on the scaffold, it is ready to be implanted into the patient and a two separate operative stages can occur. The final stage of the operation involves removing the narrow section of voicebox or upper windpipe and implanting the scaffold to reconstruct it.

Trial Locations (1)

NW1 2PG

University College London NHS Foundation Trust (UCLH), London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

University College, London

OTHER

NCT01977911 - Clinical Trial of Stem Cell Based Tissue Engineered Laryngeal Implants | Biotech Hunter | Biotech Hunter